SYSTEMIC MASTOCYTOSIS
Clinical trials for SYSTEMIC MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope: thalidomide tackles rare mast cell cancer
Disease control CompletedThis study tested the drug thalidomide in people with a rare disease called systemic mastocytosis, where too many mast cells build up in the body. The goal was to see if thalidomide could shrink the disease by cutting off its blood supply. The trial included adults whose disease …
Matched conditions: SYSTEMIC MASTOCYTOSIS
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Bone drug shows promise for rare mast cell disorder
Disease control CompletedThis study tested whether denosumab, a drug given as a shot every 6 months, can improve bone density in people with osteoporosis caused by systemic mastocytosis. 24 adults with the condition took part. The goal was to see if the drug strengthens bones and prevents fractures bette…
Matched conditions: SYSTEMIC MASTOCYTOSIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New drug flotetuzumab tested for tough blood cancers
Disease control CompletedThis early-stage trial tested the safety and best dose of flotetuzumab in 13 people with advanced blood cancers that had come back or stopped responding to treatment. Flotetuzumab is a lab-made antibody designed to block cancer cell growth. The study focused on side effects and d…
Matched conditions: SYSTEMIC MASTOCYTOSIS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC